Role and efficacy of capecitabine in the anthracycline-free regimen in breast cancer patients: a systematic review and meta-analysis

Wang, Sisi; Deng, Lufeng; Chen, Jiaren; Li, Yilin; Zhong, Yangyan; Wang, Youquan; Cao, Hong

doi:10.1007/s00432-023-05459-7

Search citation statements

Order By: Relevance

Paper Sections

Select...

Introduction1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Preprint1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 39 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Capecitabine is an oral 5-uorouracil prodrug and is widely used in the treatment of various solid tumors. It is used in breast cancer and colorectal cancer treatments due to its effectiveness, reliability and good tolerability (5,6). To this date there is only one reported case of sarcoidosis that developed after capecitabine treatment in a patient diagnosed with colon cancer (7).…”

Section: Introductionmentioning

confidence: 99%

A Case of Sarcoidosis Associated with Capecitabine

Birel,

Arslan,

Argüder

2024

Preprint

View full text Add to dashboard Cite

Sarcoidosis is a systemic disease of unknown cause with multiorgan involvement, characterized by a noncaseating granulomatous reaction. There are four groups of drugs that have been associated with the development of drug-induced sarcoid-like reactions. These are immune checkpoint inhibitors, highly active antiretroviral drugs, interferons and tumor necrosis factor-alpha antagonists. A case of sarcoidosis due to capecitabine in a patient with colorectal cancer has previously been reported in the literature. Here, we aimed to present a case of sarcoidosis that developed after adjuvant capecitabine treatment in a patient diagnosed with breast cancer.

show abstract

Section: Introductionmentioning

confidence: 99%